Michael Marchick, M.D.
Clinical Associate Professor; Associate Vice Chair of Clinical Trials
On This Page
About Michael Marchick
Dr. Marchick joined the UF faculty in 2010 following the completion of an Emergency Medicine Research Fellowship at Carolinas Medical Center in Charlotte. Prior to fellowship, Dr. Marchick graduated from Duke with a B.S. in Chemistry, received his M.D. from the University of Pittsburgh, and completed his residency in Emergency Medicine at Carolinas.
Dr. Marchick’s research interests focus on pulmonary embolism. He has been a co-investigator on several clinical trials for PE and conducts basic science research into the pathophysiology of acute pulmonary hypertension resulting from PE.
Teaching Profile
Courses Taught
-
MDC7710 – Sr Emerg Med Clerkshp
College of Medicine
-
MDT7090 – Elective Topics
College of Medicine
Board Certifications
-
Emergency MedicineAmerican Board of Emergency Medicine
Clinical Profile
Specialties
- Emergency Medicine
Areas of Interest
- High Blood Pressure – Adults
- Pulmonary Embolus
Research Profile
0000-0001-6265-2758
Areas of Interest
- pulmonary embolism
- acute pulmonary hypertension resulting from pulmonary embolism
Publications
Academic Articles
Grants
-
BNP-05-24 Medical Records Data
Active
- Role:
- Principal Investigator
- Funding:
- BECKMAN COULTER INC
-
Emergency department provider centered intervention for non-traumatic
Active
- Role:
- Co-Investigator
- Funding:
- NATL INST OF HLTH NIDCR
-
Clinical Expansion of Precision Medicine in the Emergency Department
Active
- Role:
- Project Manager
- Funding:
- NATL INST OF HLTH NHGRI
-
Access BNP Assay Clinical Subject Sample Collection Enrollment Study
Active
- Role:
- Principal Investigator
- Funding:
- BECKMAN COULTER INC
-
CTOA
Active
- Role:
- Principal Investigator
- Funding:
- UNIV OF FLORIDA
-
UTILIZATION OF TICAGRETOR IN THE UPSTREAM SETTING FOR NSTE ACUTE CORONARY SYNDROME (UPSTREAM)
- Role:
- Principal Investigator
- Funding:
- HOSPITAL QUALITY FOUNDATION via ASTRAZENECA
-
D-Dimer DVT/PE Exclusionary sample collection project
- Role:
- Principal Investigator
- Funding:
- SIEMENS HEALTHCARE DIAGNOSTICS INC
-
A Phase III, clinical study of the reversal of the anticoagulant effects of dabigatran by intravenous administration of 5.0 g idarucizumab (BI 655075) in patients treated with dabigatran etexilate who have uncontrolled bleeding… RE-VERSE-AD) trial
- Role:
- Principal Investigator
- Funding:
- BOEHRINGER INGELHEIM PHARM INC
Education
-
Residency – Emergency Medicine
Carolinas Medical Center
-
Medical Degree
University of Pittsburgh
-
Bachelor of Science
Duke University
Contact Details
- Business:
- (352) 265-5911
- Business Mailing:
-
PO Box 100186
GAINESVILLE FL 32610 - Business Street:
-
1329 SW 16th Avenue
GAINESVILLE FL 32608